Lilly’s Elanco Expects IPO to Raise $1.4B
The animal health spinoff is the second major industry player to go public, following Zoetis' successful offering.
Eli Lilly to Spin Off Animal-Health Business
Eli Lilly reported a quarterly loss of $260 million and announced plans for an IPO of Elanco by the end of 2018.
Free from Bayer, Covestro Finally Can Build for the Future
The spun-off materials science company had to build out most functions from scratch but has seen surprising early business results.
MetLife Plans Separation of U.S. Retail Business
MetLife's "bold move" could set a precedent for other "systemically important" insurers seeking to avoid higher capital requirements.
Philips Plans to IPO Lighting Unit
The proceeds of the spin-off will be used to “increase growth and drive profitability through ... disciplined capital allocation," the Dutch company said.